Constantine G. Lyketsos
#89,918
Most Influential Person Now
Professor and medical researcher
Constantine G. Lyketsos's AcademicInfluence.com Rankings
Constantine G. Lyketsosphilosophy Degrees
Philosophy
#4359
World Rank
#6843
Historical Rank
Logic
#1836
World Rank
#2685
Historical Rank
Download Badge
Philosophy Biology
Constantine G. Lyketsos's Degrees
- Masters Mental Health Johns Hopkins University
Why Is Constantine G. Lyketsos Influential?
(Suggest an Edit or Addition)According to Wikipedia, Constantine G. Lyketsos is the Elizabeth Plank Althouse Professor in Alzheimer's Disease Research in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University, Baltimore, Maryland, United States. He is the founding director of the Richman Family Precision Medicine Center of Excellence in Alzheimer's Disease, and an associate director of the Johns Hopkins Alzheimer's Disease Research Center .
Constantine G. Lyketsos's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. (2002) (1832)
- Mental and behavioral disturbances in dementia: Findings from the cache county study on memory in aging (2000) (1096)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Mood Disorders in the Medically Ill: Scientific Review and Recommendations (2005) (1009)
- Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. (2006) (887)
- Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. (2003) (861)
- Assessment and management of behavioral and psychological symptoms of dementia (2015) (776)
- Neuropsychiatric symptoms in Alzheimer’s disease (2011) (716)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Examining a bidirectional association between depressive symptoms and diabetes. (2008) (688)
- Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. (2005) (666)
- Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. (2003) (639)
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18) (2010) (620)
- Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study (2008) (600)
- Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. (2005) (583)
- Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. (2003) (484)
- Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. (2003) (455)
- Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort (2005) (438)
- Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: Application to normal elderly and Alzheimer's disease participants (2009) (438)
- Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment (2016) (435)
- Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel (2014) (407)
- Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. (2014) (406)
- Incidence and Prevalence of Dementia in the Cardiovascular Health Study (2004) (400)
- Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. (2015) (381)
- Provisional diagnostic criteria for depression of Alzheimer disease. (2002) (381)
- Nonpharmacologic management of behavioral symptoms in dementia. (2012) (363)
- Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. (2006) (352)
- Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. (2003) (350)
- Management of agitation and aggression associated with Alzheimer disease (2009) (347)
- Management of behavioral problems in Alzheimer's disease (2010) (338)
- Systematic review of the effect of psychological interventions on family caregivers of people with dementia. (2007) (321)
- Extended results of the Alzheimer’s disease anti-inflammatory prevention trial (2011) (317)
- Depression in Alzheimer’s disease: overview and treatment (2002) (316)
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
- Major and minor depression in Alzheimer's disease: prevalence and impact. (1997) (298)
- Depression Without Sadness: Functional Outcomes of Nondysphoric Depression in Later Life (1997) (296)
- Quality of life in dementia patients in long‐term care (2000) (292)
- Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future (2013) (288)
- Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study (2001) (283)
- Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. (2008) (277)
- Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study (2006) (274)
- Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. (2006) (263)
- Perspectives on depression, mild cognitive impairment, and cognitive decline. (2006) (263)
- Unmet Needs of Community‐Residing Persons with Dementia and Their Informal Caregivers: Findings from the Maximizing Independence at Home Study (2013) (260)
- Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. (2010) (260)
- Statin use and the risk of incident dementia: the Cardiovascular Health Study. (2005) (256)
- The stress and psychological morbidity of the Alzheimer patient caregiver (1999) (250)
- Depressive Symptoms as Predictors of Medical Outcomes in HIV Infection (1993) (250)
- The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. (2012) (244)
- Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study. (2015) (238)
- The Life Chart Interview: A standardized method to describe the course of psychopathology. (1994) (230)
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition (2014) (228)
- Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease (2004) (228)
- Changes in depressive symptoms as AIDS develops (1996) (223)
- Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease (2009) (221)
- The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. (2017) (219)
- Depression in Alzheimer’s disease: heterogeneity and related issues (2003) (214)
- National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. (2001) (212)
- Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. (2011) (212)
- Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms (2017) (211)
- A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease (2016) (210)
- Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. (2011) (209)
- Sertraline for the treatment of depression in Alzheimer disease. (2010) (204)
- A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long‐term care (1999) (198)
- Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study. (2000) (197)
- Underdiagnosis of Dementia: an Observational Study of Patterns in Diagnosis and Awareness in US Older Adults (2018) (195)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Treatment for mild cognitive impairment: systematic review (2013) (191)
- Physical aggression in dementia patients and its relationship to depression. (1999) (190)
- Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study. (1999) (190)
- Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging (2009) (190)
- Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia (2012) (188)
- Dementia in elderly persons in a general hospital. (2000) (181)
- Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. (2008) (181)
- Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study (2015) (178)
- Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits? (2015) (177)
- Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer’s disease (2012) (176)
- Serum ceramides increase the risk of Alzheimer disease (2012) (173)
- The General Medical Health Rating: A Bedside Global Rating of Medical Comorbidity in Patients with Dementia (1999) (170)
- Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. (1993) (168)
- Perceptions of academic vulnerability associated with personal illness: a study of 1,027 students at nine medical schools. Collaborative Research Group on Medical Student Health. (2001) (161)
- Practical Dementia Care (1999) (161)
- Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. (2004) (159)
- A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease. (1997) (157)
- The persistence of neuropsychiatric symptoms in dementia: the Cache County Study (2004) (157)
- Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. (2009) (155)
- HIV risk behaviors and their relationship to posttraumatic stress disorder among women prisoners. (2001) (154)
- The Maryland Assisted Living Study: Prevalence, Recognition, and Treatment of Dementia and Other Psychiatric Disorders in the Assisted Living Population of Central Maryland (2004) (154)
- Caregivers’ relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers’ physical health and psychological well-being (2012) (152)
- Epidemiology of apathy in older adults: the Cache County Study. (2007) (152)
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial. (2015) (151)
- Serum sphingomyelins and ceramides are early predictors of memory impairment (2010) (148)
- Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates (2000) (148)
- The association of neuropsychiatric symptoms and environment with quality of life in assisted living residents with dementia. (2005) (147)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- Atypical antipsychotic use in patients with dementia: managing safety concerns. (2012) (139)
- Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay. (2002) (136)
- A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long‐term care (2004) (126)
- Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. (2010) (126)
- Incidence, prevalence, and outcomes of depression in residents of a long‐term care facility with dementia (2002) (125)
- Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. (2002) (124)
- Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. (2009) (123)
- Wandering behaviour in community‐residing persons with dementia (1999) (123)
- Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus (2018) (122)
- Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss (2010) (122)
- Delusions and hallucinations in Alzheimer's disease: review of the brain decade. (2003) (122)
- Preoperative risk factors for postoperative delirium following hip fracture repair: a systematic review (2015) (121)
- Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. (2011) (121)
- Imaging of Glial Cell Activation and White Matter Integrity in Brains of Active and Recently Retired National Football League Players (2017) (120)
- Correlates of objective and subjective measures of caregiver burden among dementia caregivers: influence of unmet patient and caregiver dementia-related care needs (2014) (117)
- Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets? (2010) (117)
- Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. (2012) (116)
- A follow‐up study of change in quality of life among persons with dementia residing in a long‐term care facility (2003) (116)
- Influence of social network characteristics on cognition and functional status with aging (2008) (114)
- A multidimensional home-based care coordination intervention for elders with memory disorders: the maximizing independence at home (MIND) pilot randomized trial. (2014) (113)
- Depression and cardiac morbidity 5 years after coronary artery bypass surgery. (2002) (112)
- Prevalence and correlates of depression in late life: a population based study from a rural Greek town (2005) (112)
- The benefits and risks of ECT for patients with primary dementia who also suffer from depression (2000) (112)
- Screening for Psychiatric Morbidity in a Medical Outpatient Clinic for HIV Infection: The Need for a Psychiatric Presence (1994) (107)
- Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging. (2019) (106)
- Psychosomatic Medicine: A New Psychiatric Subspecialty (2004) (106)
- The epidemiology of psychosis in dementia. (2003) (103)
- Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions. (2002) (103)
- Characteristics and outcomes of dementia residents in an assisted living facility (2000) (102)
- Apathy and cognitive and functional decline in community-dwelling older adults: results from the Baltimore ECA longitudinal study (2010) (102)
- Practice effects predict cognitive outcome in amnestic mild cognitive impairment. (2011) (102)
- Cannabis use and cognitive decline in persons under 65 years of age. (1999) (101)
- The incidence of mental and behavioral disturbances in dementia: the cache county study. (2003) (101)
- DTI analyses and clinical applications in Alzheimer's disease. (2011) (100)
- Manic syndrome early and late in the course of HIV. (1993) (99)
- Vascular dementia and Alzheimer's disease: is there a difference? A comparison of symptoms by disease duration. (2000) (99)
- Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. (2005) (99)
- Psychiatric aspects of traumatic brain injury. (2002) (98)
- Effects of non‐steroidal anti‐inflammatory drug treatments on cognitive decline vary by phase of pre‐clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti‐inflammatory Prevention Trial (2011) (98)
- Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction (2011) (97)
- Systematic review of neuroimaging correlates of executive functioning: converging evidence from different clinical populations. (2014) (94)
- Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia (2015) (93)
- Predictors of functional impairment in residents of assisted-living facilities: the Maryland Assisted Living study. (2005) (93)
- Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease (2013) (92)
- Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments (2007) (90)
- Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. (2009) (88)
- A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of ‘vascular depression’ (2001) (87)
- Depression and Type 2 Diabetes Mellitus: The Multiethnic Study of Atherosclerosis (2007) (87)
- Mood disorders in HIV infection (1998) (86)
- An evidence‐based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease (2001) (86)
- Psychiatric morbidity on entry to an HIV primary care clinic (1996) (85)
- Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators. (2004) (85)
- Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers (2019) (83)
- Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H‐NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic (2004) (83)
- The Fornix Sign: A Potential Sign for Alzheimer's Disease Based on Diffusion Tensor Imaging (2012) (83)
- Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial. (2012) (83)
- Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. (1996) (82)
- Race and restless legs syndrome symptoms in an adult community sample in east Baltimore. (2006) (78)
- Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. (1997) (77)
- Diagnosis and Treatment of Depression in Alzheimer’s Disease (2003) (76)
- Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study (2008) (76)
- Quality of life of community-residing persons with dementia based on self-rated and caregiver-rated measures (2012) (75)
- Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias. (1998) (75)
- Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1. (2016) (73)
- Caring for Medical Students as Patients: Access to Services and Care‐seeking Practices of 1,027 Students at Nine Medical Schools (2000) (73)
- Depression and incident Alzheimer disease: the impact of disease severity. (2015) (72)
- Does NSAID use modify cognitive trajectories in the elderly? (2007) (72)
- Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study. (2011) (71)
- Cognitive function after 11.5 years of alcohol use: relation to alcohol use. (2002) (70)
- Elevated plasma ceramides in depression. (2011) (69)
- Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects (2018) (69)
- Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study (2015) (68)
- Pharmacological treatment of neuropsychiatric symptoms of dementia. (2005) (67)
- MAP Kinase Signaling Cascade Dysfunction Specific to Alzheimer's Disease in Fibroblasts (2002) (66)
- Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. (2012) (65)
- Depression in assisted living is common and related to physical burden. (2006) (64)
- Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial. (2016) (64)
- Telemedicine Use and the Reduction of Psychiatric Admissions from a Long-Term Care Facility (2001) (63)
- A clinical approach to mild cognitive impairment. (2006) (63)
- Nulliparity and late menopause are associated with decreased cognitive decline. (2003) (62)
- Alzheimer’s disease and the fornix (2014) (62)
- Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. (2012) (61)
- Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation. (2018) (61)
- Predictors of progression to severe Alzheimer’s disease in an incidence sample (2013) (60)
- Home is where the future is: The BrightFocus Foundation consensus panel on dementia care (2018) (60)
- Secondary mania in patients with HIV infection: are antiretrovirals protective? (1999) (59)
- Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study. (2016) (59)
- Unmet needs in community-living persons with dementia are common, often non-medical and related to patient and caregiver characteristics (2019) (59)
- Lipids and the pathogenesis of Alzheimer's disease: Is there a link? (2006) (58)
- Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: The Cache County Study (2008) (57)
- Reducing neuropsychiatric symptoms in persons with dementia and associated burden in family caregivers using tailored activities: Design and methods of a randomized clinical trial. (2016) (57)
- The physical environment influences neuropsychiatric symptoms and other outcomes in assisted living residents (2010) (57)
- Epidemiology, assessment, and treatment of dementia. (2011) (57)
- Pharmacological management of the psychiatric aspects of traumatic brain injury (2003) (57)
- Practice guideline for the treatment of patients with HIV/AIDS. Work Group on HIV/AIDS. American Psychiatric Association. (2000) (56)
- Psychiatric manifestations of neurologic disease: where are we headed? (2007) (56)
- A randomized controlled trial of a community-based dementia care coordination intervention: effects of MIND at Home on caregiver outcomes. (2015) (55)
- Treatment of sleep disturbance in Alzheimer's dementia (2011) (55)
- Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial (2014) (55)
- Depression in Cognitive Impairment (2013) (55)
- Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS‐2)? (2011) (54)
- Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study. (2012) (54)
- Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study. (2020) (53)
- Age at menopause and duration of reproductive period in association with dementia and cognitive function: A systematic review and meta-analysis (2016) (53)
- Major depression in Alzheimer's disease. An interaction between gender and family history. (1996) (53)
- Citalopram for agitation in Alzheimer’s disease: Design and methods (2012) (52)
- Apolipoprotein E Genotype and Mortality: Findings from the Cache County Study (2005) (52)
- Dementia severity and the longitudinal costs of informal care in the Cache County population (2015) (52)
- Systematic review of the effectiveness of pharmacologic interventions to improve quality of life and well-being in people with dementia. (2013) (52)
- Depressive symptoms over the course of HIV infection before AIDS (1996) (52)
- Mild cognitive impairment: searching for the prodrome of Alzheimer's disease (2008) (51)
- Addressing the ethical, legal, and social issues raised by voting by persons with dementia. (2004) (51)
- Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. (2004) (51)
- Psychiatric disorders and HIV infection: impact on one another. (1995) (51)
- Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study (2012) (50)
- Risk of mortality with vitamin E supplements: the Cache County study. (2007) (50)
- Predictors of quality of life ratings for persons with dementia simultaneously reported by patients and their caregivers: the Cache County (Utah) Study (2012) (50)
- The Prevalence of Psychiatric Disorders in Sexually Transmitted Disease Clinic Patients and Their Association With Sexually Transmitted Disease Risk (2004) (49)
- Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study (2015) (49)
- Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study (2005) (49)
- Nulliparity and Late Menopause Are Associated With Decreased Cognitive Decline (2003) (48)
- Dementia caregivers’ coping strategies and their relationship to health and well-being: the Cache County Study (2015) (48)
- Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. (2012) (48)
- Forgotten frontal lobe syndrome or "Executive Dysfunction Syndrome". (2004) (48)
- The Cache County Study on Memory in Aging: Factors affecting risk of Alzheimer's disease and its progression after onset (2013) (47)
- Rapidly progressive dementias and the treatment of human prion diseases (2011) (46)
- Predictors of dementia caregiver depressive symptoms in a population: the Cache County dementia progression study. (2013) (46)
- Long-term outcomes of galantamine treatment in patients with Alzheimer disease. (2004) (46)
- Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma. (2010) (46)
- Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study (2014) (45)
- Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease (2013) (45)
- Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. (2016) (44)
- Provisional diagnostic criteria for depression of Alzheimer’s disease: description and review (2003) (44)
- Mild behavioral impairment: A prodromal stage of dementia (2008) (43)
- Visual and Cognitive Predictors of Performance on Brake Reaction Test: Salisbury Eye Evaluation Driving Study (2007) (43)
- Neuropsychiatric Disturbances Associated with Traumatic Brain Injury: A Practical Approach to Evaluation and Management (2015) (42)
- The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging. (2017) (42)
- Multi-Modal MRI Analysis with Disease-Specific Spatial Filtering: Initial Testing to Predict Mild Cognitive Impairment Patients Who Convert to Alzheimer’s Disease (2011) (42)
- Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography. (2012) (42)
- Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study. (2005) (41)
- Relationship of self-perceptions of memory and worry to objective measures of memory and cognition in the general population. (2003) (41)
- A Descriptive Study of Home Modifications for People with Dementia and Barriers to Implementation (2011) (41)
- Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease (2012) (41)
- Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS). (2004) (41)
- Tools for multiple granularity analysis of brain MRI data for individualized image analysis (2014) (41)
- Diagnostic criteria for apathy in neurocognitive disorders (2021) (40)
- When Less is More, but Still Not Enough: Why Focusing on Limiting Antipsychotics in People With Dementia Is the Wrong Policy Imperative. (2019) (40)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS (2006) (39)
- Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design (2014) (39)
- Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia. (2015) (39)
- Clinical application of operationalized criteria for ‘Depression of Alzheimer's Disease’ (2005) (39)
- Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer’s Disease: A Review of the Literature (2015) (39)
- Delayed post-hypoxic leukoencephalopathy. (2001) (39)
- Association of a Care Coordination Model With Health Care Costs and Utilization (2018) (38)
- Nutritional Status is Associated With Severe Dementia and Mortality: The Cache County Dementia Progression Study (2018) (38)
- Effects of Food and Drug Administration-approved medications for Alzheimer’s disease on clinical progression (2012) (38)
- Antipsychotic drugs in dementia: what should be made of the risks? (2005) (38)
- Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease. (2011) (37)
- Design of Depression in Alzheimer's Disease Study-2. (2006) (36)
- The relationship between delusions and depression in Alzheimer's disease (2002) (36)
- Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale. (2018) (36)
- Apolipoprotein E genotype and lifetime cognitive decline (2008) (36)
- Quality of life in dementia patients in Athens, Greece: predictive factors and the role of caregiver-related factors (2010) (35)
- Health Services Utilization in Older Adults with Dementia Receiving Care Coordination: The MIND at Home Trial (2018) (35)
- What and How Psychiatry Residents at Ten Training Programs Wish to Learn About Ethics (1996) (35)
- Sociodemographic Correlates of Cognition in the Multi-Ethnic Study of Atherosclerosis (MESA). (2015) (35)
- Does stroke cause depression? (1998) (34)
- Poster Presentations P1 P192 P1-067 THE MEASUREMENT OF EVERYDAY COGNITION (ECOG): DEVELOPMENT AND VALIDATION OF A SHORT VERSION (34)
- A suicidal adult in crisis: an unexpected diagnosis of autism spectrum disorder. (2011) (34)
- Caregiver report versus clinician impression: disagreements in rating neuropsychiatric symptoms in Alzheimer's disease patients (2015) (33)
- Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study (2014) (33)
- Effect of the WeCareAdvisor™ on family caregiver outcomes in dementia: a pilot randomized controlled trial (2018) (32)
- Insomnia and daytime sleepiness in people with dementia residing in assisted living: findings from the Maryland Assisted Living Study (2008) (32)
- The Prevalence and Specificity of Depression Diagnosis in a Clinic-Based Population of Adults With Type 2 Diabetes Mellitus. (2017) (32)
- Predictors of providing informed consent or assent for research participation in assisted living residents. (2008) (31)
- The association of traumatic brain injury with rate of progression of cognitive and functional impairment in a population-based cohort of Alzheimer's disease: the Cache County Dementia Progression Study* (2014) (31)
- Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression Study (2016) (31)
- Caregiver personality predicts rate of cognitive decline in a community sample of persons with Alzheimer's disease. The Cache County Dementia Progression Study (2013) (31)
- Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities (2022) (31)
- The association of minor and major depression with health problem-solving and diabetes self-care activities in a clinic-based population of adults with type 2 diabetes mellitus. (2017) (30)
- Fornix-Region Deep Brain Stimulation-Induced Memory Flashbacks in Alzheimer's Disease. (2019) (30)
- Effect of Dementia and Treatment of Dementia on Time to Discharge from Assisted Living Facilities: The Maryland Assisted Living Study (2007) (29)
- The spectrum of medical illness and medication use among residents of assisted living facilities in central Maryland. (2008) (29)
- A Population Study of Alzheimer’s Disease: Findings From the Cache County Study on Memory, Health, and Aging (2005) (29)
- Deep brain stimulation: a novel strategy for treating Alzheimer's disease. (2012) (28)
- Latent class‐derived subgroups of depressive symptoms in a community sample of older adults: the Cache County Study (2012) (28)
- Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. (2018) (28)
- Successful multimodality treatment of severe behavioral disturbance in a patient with advanced Huntington's disease. (2001) (28)
- Amantadine for executive dysfunction syndrome in patients with dementia. (2004) (28)
- Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease. (2012) (28)
- Alcohol consumption as a cofactor in the progression of HIV infection and AIDS. (1995) (28)
- A comparison of small and large assisted living facilities for the diagnosis and care of dementia: the Maryland Assisted Living Study (2007) (27)
- Correlates of caregiver-rated quality of life in assisted living: the Maryland Assisted Living study. (2006) (27)
- Transition to nursing home from assisted living is not associated with dementia or dementia-related problem behaviors. (2006) (27)
- Tricyclic antidepressants and cognitive decline. (2002) (27)
- The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia (2013) (27)
- R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. (2016) (27)
- Prevention of unnecessary hospitalization for patients with dementia: the role of ambulatory care. (2012) (27)
- First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 (2015) (27)
- Association of the Spatial Layout of the Home and ADL Abilities Among Older Adults With Dementia (2011) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19 (2021) (26)
- The association between activity participation and time to discharge in the assisted living setting (2008) (26)
- Depression and survival among HIV-infected persons. (1996) (26)
- Correlates of functional dependence among recently admitted assisted living residents with and without dementia. (2009) (25)
- Clozapine for Treatment-Resistant Agitation in Dementia (2007) (25)
- Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies (2008) (25)
- Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. (2015) (25)
- A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease. (2018) (25)
- The effectiveness of psychiatric treatment for HIV-infected patients. (1997) (25)
- Identifying the Barriers and Challenges to Voting by Residents in Nursing Homes and Assisted Living Settings (2008) (24)
- Neuropsychiatric Symptoms in Dementia: Overview and Measurement Challenges. (2015) (24)
- Surface-Based Analysis on Shape and Fractional Anisotropy of White Matter Tracts in Alzheimer's Disease (2010) (24)
- Frontotemporal dementia: a clinicopathological review of four postmortem studies. (1996) (24)
- Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study (2004) (24)
- AIDS mania. (1997) (23)
- Lessons from neuropsychiatry. (2006) (23)
- Comparing proxy rated quality of life of people living with dementia in care homes (2019) (23)
- Mania in Alzheimer's disease. (1995) (23)
- Addressing the Alzheimer's disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes (2012) (23)
- Clinicopathological correlates of depression in early Alzheimer's disease in the NACC (2016) (23)
- Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial (2015) (23)
- WeCareAdvisor™: The Development of a Caregiver-focused, Web-based Program to Assess and Manage Behavioral and Psychological Symptoms of Dementia (2017) (22)
- Case Study: Johns Hopkins Community Health Partnership: A model for transformation. (2016) (21)
- Neuropsychiatric symptoms in dementia patients with and without a history of traumatic brain injury. (2010) (21)
- Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer’s Disease (2018) (21)
- Adjustment to residential placement in Alzheimer disease patients: does premorbid personality matter? (1998) (21)
- Depression and diabetes: more on what the relationship might be. (2010) (20)
- Mania in temporal lobe epilepsy (1993) (20)
- Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial (2019) (20)
- The Time Is Now to Address Behavioral Symptoms of Dementia (2014) (20)
- Comprehensive home-based care coordination for vulnerable elders with dementia: Maximizing Independence at Home-Plus—Study protocol (2017) (20)
- A Call to Restructure Psychiatry General and Subspecialty Training (2016) (19)
- A commentary on the proposed DSM revision regarding the classification of cognitive disorders. (2011) (19)
- The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial (2019) (19)
- Should pregnant women avoid eating fish? Lessons from the Seychelles (2003) (19)
- Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia (2018) (19)
- Predictor index of mortality in dementia patients upon entry into long-term care. (2001) (18)
- IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease (2009) (18)
- Progress in Treatment Development for Neuropsychiatric Symptoms in Alzheimer's Disease: Focus on Agitation and Aggression. A Report from the EU/US/CTAD Task Force. (2015) (18)
- Falls and Age in Patients With Alzheimer's Disease (2004) (18)
- Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease. (2016) (18)
- Caregiver-Care Recipient Relationship Closeness is Associated With Neuropsychiatric Symptoms in Dementia. (2019) (18)
- Susceptibility to Fluoroquinolones of Vibrio cholerae O1 Isolated From Diarrheal Patients in Zimbabwe (2013) (18)
- The care of patients with dementia (1995) (18)
- Comparison of Unmet Care Needs across The Dementia Trajectory: Findings from The Maximizing Independence at Home Study (2014) (17)
- Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram? (2011) (17)
- 12-month incidence, prevalence, persistence, and treatment of mental disorders among individuals recently admitted to assisted living facilities in Maryland (2013) (17)
- A randomized trial of a web-based platform to help families manage dementia-related behavioral symptoms: The WeCareAdvisor™. (2017) (17)
- Evaluation and treatment of psychiatric disorders associated with HIV infection (1992) (17)
- Atlas-based diffusion tensor imaging correlates of executive function. (2015) (17)
- Head injury serum markers for assessing response to trauma: Design of the HeadSMART study (2017) (17)
- Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force. (2018) (17)
- Neuropsychiatric symptoms in patients with dementia and the longitudinal costs of informal care in the Cache County population (2019) (17)
- A Multipronged, Adaptive Approach for the Recruitment of Diverse Community-Residing Elders with Memory Impairment: The MIND at Home Experience. (2015) (16)
- Identifying Dementia in High-Risk Community Samples: The Memory and Medical Care Study (2003) (16)
- Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline (2014) (16)
- A population‐based study of the association between coronary artery bypass graft surgery (CABG) and cognitive decline: the Cache County study (2006) (16)
- Predictors of caregiver unawareness and nontreatment of dementia among residents of assisted living facilities: the Maryland Assisted Living Study. (2006) (16)
- THE PATHOPHYSIOLOGY OF ALZHEIMER'S DISEASE AND DIRECTIONS IN TREATMENT (2005) (16)
- Implementation of a comprehensive program to improve coordination of care in an urban academic health care system. (2018) (16)
- MIND at Home-Streamlined: Study protocol for a randomized trial of home-based care coordination for persons with dementia and their caregivers. (2018) (15)
- Brain structures and networks responsible for stimulation‐induced memory flashbacks during forniceal deep brain stimulation for Alzheimer's disease (2021) (15)
- Psychiatric care for patients with HIV infection. The varying perspectives. (1993) (15)
- Caregiver coping strategies predict cognitive decline in dementia: The Cache County Dementia Progression Study (2010) (14)
- CHARACTERISTICS AND OUTCOMES FOR ASSISTED LIVING RESIDENTS WITH DEMENTIA: COMPARING DEMENTIA‐SPECIFIC CARE UNITS WITH NON–DEMENTIA‐SPECIFIC CARE UNITS (2008) (14)
- Dextromethorphan/Quinidine (AVP-923) Efficacy and Safety for Treatment of Agitation in Persons With Alzheimer’s Disease: Results From a Phase 2 Study (NCT01584440) (S16.007) (2015) (14)
- Sertraline for the Treatment of Depression in Alzheimer Disease: Genetic Influences (2011) (14)
- Psychosomatic medicine: A new psychiatric subspecialty in the U.S. focused on the interface between psychiatry and medicine (2006) (14)
- Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia (2020) (14)
- Deep brain stimulation targeting the fornix for mild Alzheimer dementia: design of the ADvance randomized controlled trial (2015) (13)
- Searching for valid psychiatric phenotypes: discrete latent variable models (2010) (13)
- Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care (2018) (13)
- Modifying dementia risk and trajectories of cognitive decline in aging: The Cache County Memory Study (2006) (13)
- Plasma Ceramides Are Elevated in Depression (2011) (13)
- Memantine discontinuation and the health status of nursing home residents with Alzheimer's disease. (2010) (13)
- Beyond memory: a focus on the other neuropsychiatric symptoms of dementia. (2015) (13)
- Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2. (2014) (13)
- Behavioural health interventions in the Johns Hopkins Community Health Partnership: Integrated care as a component of health systems transformation (2014) (13)
- The interface between depression and dementia: where are we with this important frontier? (2010) (12)
- Stressful life events and cognitive decline: Sex differences in the Baltimore Epidemiologic Catchment Area Follow‐Up Study (2019) (12)
- P1-284: In vivo imaging of amyloid deposition in Alzheimer's disease using the novel radioligand [18F] Av-45 (2008) (12)
- A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation (2015) (12)
- Special Issue on mild behavioral impairment and non-cognitive prodromes to dementia (2018) (12)
- UNMET NEEDS OF COMMUNITY-RESIDING PERSONS WITH DEMENTIA (2018) (12)
- Diagnosis and Management of Delirium in the Elderly (1999) (12)
- Differentiating Alzheimer’s Disease and Frontotemporal Dementia: Receiver Operator Characteristic Curve Analysis of Four Rating Scales (1998) (12)
- Mouse Models of Alzheimer's Disease (2010) (12)
- Citalopram for the Treatment of Agitation in Alzheimer Dementia (2016) (12)
- Anxiety symptoms among assisted living residents: implications of the "no difference" finding for participants with and without dementia. (2008) (11)
- Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: Conceptual framework and example (2014) (11)
- Isolated hallucinosis in Alzheimer's disease is associated with African–American race (2002) (11)
- Dementia in Patients With Schizophrenia: Evidence for Heterogeneity. (2015) (11)
- Risk factors for severe dementia from a population-based sample of incident Alzheimer's Disease: The Cache County Dementia Progression Study. (2011) (11)
- The impact of complex chronic diseases on care utilization among assisted living residents. (2014) (11)
- History of traumatic brain injury interferes with accurate diagnosis of Alzheimer’s dementia: a nation-wide case-control study (2019) (10)
- Major depression and its response to sertraline in primary care vs. psychiatric office practice patients. Results of an open-label trial in Argentina. (1999) (10)
- Loss of consciousness and altered mental state predicting depressive and post-concussive symptoms after mild traumatic brain injury (2019) (10)
- Promoting Careers in Academic Research to Psychiatry Residents (2014) (10)
- ADAPT trial data. (2007) (10)
- Cost-Effective Care Coordination for People With Dementia at Home (2020) (10)
- A randomized, placebo-controlled, double-blind, clinical trial of sertraline in the treatment of major depression complicating Alzheimer disease: Initial results from the diads study (2000) (10)
- Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention (2008) (10)
- Treating dementia : do we have a pill for it? (2009) (10)
- Companion to Clinical Neurology, 2nd ed. (2004) (10)
- Effects of the tailored activity program (TAP) on dementia-related symptoms, health events and caregiver wellbeing: a randomized controlled trial (2021) (9)
- Association of Hearing Loss With Neuropsychiatric Symptoms in Older Adults With Cognitive Impairment. (2020) (9)
- Apo-E genotype and verbal deficits in Alzheimer's disease. (1996) (9)
- Cognitive Gains and Losses of Patients with Alzheimer's Disease During Frequent Practice (1995) (9)
- Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease (2006) (9)
- Psychiatric issues and emergencies in HIV infection. (1995) (9)
- Mapping autonomic, mood, and cognitive effects of hypothalamic region deep brain stimulation. (2021) (9)
- Rates of Depression in Individuals With Pathologic But Not Clinical Alzheimer Disease are Lower Than Those in Individuals Without the Disease: Findings From the Baltimore Longitudinal Study on Aging (BLSA) (2007) (9)
- Commentary on “Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.” New criteria for a new era (2011) (8)
- Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease (2022) (8)
- The association of neuropsychiatric symptoms with regional brain volumes from patients in a tertiary multi-disciplinary memory clinic (2020) (8)
- Gross feature recognition of Anatomical Images based on Atlas grid (GAIA): Incorporating the local discrepancy between an atlas and a target image to capture the features of anatomic brain MRI☆ (2013) (8)
- Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients. (2021) (8)
- The trap of meaning: a public health tragedy. (2009) (8)
- The Historical Development and State of the Art Approach to Design and Delivery of Dementia Care Services (2013) (8)
- Erratum: Position statement of the American Association for geriatric psychiatry regarding principles of care for patients with dementia due to Alzheimer disease (The American Journal of Geriatic Psychiatry 14, 7 (561-573)) (2006) (8)
- Major Depression and Cognitive Decline After 11.5 Years: Findings from the ECA Study (2003) (8)
- Age differences in outcome after mild traumatic brain injury: results from the HeadSMART study (2020) (8)
- The Effects of ELND005 (Scyllo-Inositol) on Emergence of Neuropsychiatric Symptoms (NPS) in Mild/Moderate Alzheimer's Disease: Results from a 78-Week Phase 2 Study (P04.215) (2012) (7)
- Bilateral Cortical Encephalomalacia in a Patient Implanted With Bilateral Deep Brain Stimulation for Alzheimer’s Disease: A Case Report (2016) (7)
- Psychiatric Disorders in HIV-Infected Patients (1995) (7)
- Editorial: Alzheimer's Disease and the Fornix (2016) (7)
- Beyond the DSM: the perspectives of psychiatry approach to patients. (2012) (7)
- Psychopathology in dementia (1994) (7)
- Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia (2019) (7)
- Citalopram compared to atypical antipsychotics for Alzheimer patients who did not previously benefit from treatment: The catie-AD study (2009) (7)
- A PROINFLAMMATORY ENDOPHENOTYPE PREDICTS TREATMENT RESPONSE IN A MULTICENTER TRIAL OF NSAIDS IN AD (2014) (7)
- 130 Bilateral Fornix Deep Brain Stimulation for Alzheimer Disease: Surgical Safety in the ADvance Trial (2015) (7)
- Dementia and Milder Cognitive Syndromes (2013) (7)
- Use of the Brief Psychiatric Rating Scale as a Predictor of Psychiatric Admission for Non-Suicidal Patients (1998) (7)
- A Quantitative MRI Study of the Basal Ganglia in Depression in HIV Seropositive Men. (1996) (6)
- Antihypertensive Medication Use and Incident Alzheimer Disease (2017) (6)
- Treatment Development for Alzheimer's Disease: How Are We Doing? (2020) (6)
- Population Pharmacokinetic Modeling of Sertraline Treatment in Patients With Alzheimer Disease: The DIADS‐2 Study (2013) (6)
- Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic. (1996) (6)
- Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer's Dementia and Death: The Cache County Study (2014) (6)
- Comment on “Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment” (2018) (6)
- WeCareAdvisor, an Online Platform to Help Family Caregivers Manage Dementia-Related Behavioral Symptoms: an Efficacy Trial in the Time of COVID-19 (2021) (6)
- Apathy and agitation: challenges and future directions. (2007) (6)
- Cortical Beta-Amyloid Deposition in Late-Life Depression (2013) (6)
- Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease (2021) (5)
- Behavioral neurology and neuropsychiatry fellowship training: the Johns Hopkins model. (2009) (5)
- Depressive syndromes and causal associations. (1996) (5)
- Cohort differences in dementia recognition and treatment indicators among assisted living residents in Maryland: did a change in the resident assessment tool make a difference? (2013) (5)
- Interaction between vascular factors and the APOE E4 allele predict rate of progression in Alzheimer's dementia (2011) (5)
- HIV infection in Maryland public psychiatric facilities: results of an informal survey. (1993) (5)
- Design and Implementation of a Regional Inpatient Psychiatry Unit for Patients who are Positive for Asymptomatic SARS-CoV-2 (2020) (5)
- An Open-Label Trial of Sertraline for the Treatment of Major Depression in Primary Care (1999) (5)
- A Broad Symmetry Criterion for Nonparametric Validity of Parametrically Based Tests in Randomized Trials (2012) (5)
- Childless Elders in Assisted Living: Findings from the Maryland Assisted Living Study (2013) (5)
- How do neuropsychiatric symptoms in persons with dementia affect caregiver physical and mental health over time? the cache county dementia progression study (2015) (4)
- Drug Discovery and Development for Alzheimer's Disease (2002) (4)
- Treating agitation in dementia (2011) (4)
- Principal components analysis of agitation outcomes in Alzheimer's disease. (2016) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Cloud-Based Brain Magnetic Resonance Image Segmentation and Parcellation System for Individualized Prediction of Cognitive Worsening (2019) (4)
- Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD) (2020) (4)
- Characterizing Highly Benefited Patients in Randomized Clinical Trials (2017) (4)
- EditorialPsychiatric aspects of traumatic brain injury: new solutions to an old problem (2003) (4)
- Automated Generation of Radiologic Descriptions on Brain Volume Changes From T1-Weighted MR Images: Initial Assessment of Feasibility (2019) (4)
- Successful treatment of bowel obsessions with nortriptyline. (1992) (4)
- Higher caregiver agreeableness predicts slower cognitive decline in persons with Alzheimer's disease: The dementia progression study (2010) (4)
- Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria (2021) (4)
- Prenatal methylmercury exposure in the Seychelles (2003) (4)
- Psychiatric aspects of neurologic diseases : practical approaches to patient care (2008) (4)
- Plasma sphingomyelin is associated with cognitive progression in Alzheimer's Disease (2011) (3)
- Neuropsychiatric symptoms at baseline predict shorter time to severe dementia in a population-based sample of incident Alzheimer's disease: The Cache County Dementia Progression Study (2012) (3)
- Depression in Patients With Alzheimer Dementia (2006) (3)
- P1-387: Modeling dementia trajectories: An application of dynamical correlations to age-related traits in the Cache County Dementia Progression Study (2008) (3)
- Loss of Consciousness and Altered Mental State as Predictors of Functional Recovery Within 6 Months Following Mild Traumatic Brain Injury. (2019) (3)
- The dementia of Gerstmann-Sträussler-Scheinker syndrome: clinical variability demonstrated by two case reports. (1995) (3)
- Dementia and Mild Neurocognitive Disorders (2015) (3)
- Training in psychosomatic medicine: a psychiatric subspecialty recognized in the United States by the American board of medical specialties. (2011) (3)
- Vascular factors as predictors of severe dementia and mortality in Alzheimer's disease: The Cache County dementia progression study (2013) (3)
- Pharmacological Therapies in Alzheimer's Disease (2010) (3)
- Longitudinal Trajectories of Clinical Decline in Amyloid Positive and Negative Populations. (2016) (3)
- Definitions and Overview of the Book (2006) (3)
- Longitudinal Course of Agitation and Aggression in Patients with Alzheimer’s Disease in a Cohort study: Methods, Baseline and Longitudinal Results of the A3C Study (2020) (3)
- Pharmacotherapy of neuropsychiatric symptoms: opportunities, challenges and current prospects (2007) (3)
- Cholinesterase Inhibitors and Memantine (2008) (3)
- “WECARE ADVISOR”: A CLINICAL TRIAL OF A CAREGIVER FOCUSED, IPAD ADMINISTERED ALGORITHM TO MANAGE BEHAVIORAL SYMPTOMS (2016) (3)
- Noncognitive functional Disorders and Disturbances in Sleeping, Eating, and Sexuality (2006) (2)
- Effects of oral ELND005 (scyllo-inositol) on neuropsychiatric symptoms in a 78-week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo-inositol reduction (2012) (2)
- OPTIMIZING MEASUREMENT OF AGITATION AND AGGRESSION IN DEMENTIA (2017) (2)
- Neuroanatomical Correlates of Cognitive and Neuropsychiatric Worsening in Alzheimer's Disease: Whole-Brain Longitudinal DTI Analysis (P03.092) (2012) (2)
- Validity and reliability of the neuropsychiatric inventory-clinician rating scale (NPI-C)© in a Brazilian multicenter study: Assessment of neuropsychiatric symptoms in dementia (2013) (2)
- Pharmacologic Treatments for Neuropsychiatric Symptoms (2016) (2)
- UNMET NEEDS OF DEMENTIA CAREGIVERS AT HOME (2018) (2)
- The associations between unmet needs with protective factors, risk factors and outcomes among care partners of community-dwelling persons living with dementia (2022) (2)
- Efficacy of a multidimensional home-based care coordination intervention for elders with memory disorders: The Maximizing Independence at Home (MIND at Home) trial (2012) (2)
- DEPRESSION AND CD4 DECLINE. AUTHORS' REPLY (1994) (2)
- Citalopram for Agitation in AD (CitAD): Pharmacokinetic Studies, Subgroup Analyses, and Effect on Other Neuropsychiatric Symptoms (2016) (2)
- Veterans have less age-related cognitive decline. (2000) (2)
- P2-247 A population based study of medical co-morbidity in early dementia and mild cognitive syndrome: association with functional and cognitive impairment (2004) (2)
- Quantifying translocator protein (TSPO) in Alzheimer's disease and cognitively healthy older persons with 11C-DPA-713 PET imaging (2011) (2)
- P3-483: Memantine discontinuation in nursing home residents with Alzheimer's disease was associated with an increase in Alzheimer's disease symptoms (2008) (2)
- Engaging an Asian Immigrant Older Adult in Depression Care: Collaborative Care, Patient-Provider Communication and Ethnic Identity. (2021) (2)
- The Relationship between Neuropsychiatric Symptoms and Cognitive Performance in Older Adults with Normal Cognition (2022) (2)
- Association between Motor Signs and Cognitive Performance in Cognitively Unimpaired Older Adults: A Cross-Sectional Study Using the NACC Database (2022) (2)
- Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer’s Disease (2021) (2)
- Commentary Insulin Resistance as a Link Between Affective Disorder and Alzheimer's Disease: A Hypothesis in Need of Further Refinement (2004) (2)
- Perspectives Neuropsychiatric symptoms in Alzheimer's disease (2011) (2)
- Book Review: Systematic Psychiatric Evaluation: A Step-by-Step Guide to Applying the Perspectives of Psychiatry (2012) (2)
- NSAID use does not affect dementia progression or survival in Alzheimer's disease. The Cache County Dementia Progression Study. (2011) (2)
- Caregiver coping strategies predict neuropsychiatric symptoms in dementia: The Cache County Dementia Progression Study (2012) (2)
- Generation and characterization of a novel human iPSC line from a resilient Alzheimer's disease patient. (2020) (1)
- Dr. Onyike and Colleagues Reply (2004) (1)
- Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker (2015) (1)
- PL-3-1 Neuropsychiatric symptoms of dementia: nature and treatment (2004) (1)
- The Evaluation and Formulation of Dementia (2006) (1)
- O2-01-08: Assocation between neuropsychiatric syndromes and mortality in a population-based sample of incident Alzheimer's disease and other dementias: The Cache County dementia progression study (2008) (1)
- Depression and CD4 Decline-Reply (1994) (1)
- Complimentary Subspecialties: Consultation-Liaison Psychiatry and Neuropsychiatry. (2021) (1)
- Application of clinical epidemiologic methods to the clinical practice of psychiatry. (1994) (1)
- Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer’s disease (2022) (1)
- Change in 12‐month health care utilization patterns among persons living with dementia who received a comprehensive home‐based dementia care coordination program: Mind at home (2020) (1)
- O3-01-07 Anti-hypertensive medication use may reduce risk of incident Alzheimer's disease. The Cache County Study (2004) (1)
- Caregiver Agreeableness, Neuroticism, Openness and Extraversion Associated with Cognitive Decline in Persons with Alzheimer’s Disease: The Cache County Dementia Progression Study (2011) (1)
- Tracking the Clinical Psychiatric Literature (1991) (1)
- The Wecareadvisor™: a Web-Based Tool to HELP Family Caregivers Manage the Behavioral and Psychological Symptoms of Dementia (2017) (1)
- Influence of study population definition on the effect of age on outcomes after blunt head trauma (2018) (1)
- Benefits of home‐based dementia care on clinical and quality‐of‐life outcomes for persons living with dementia and their carers (2020) (1)
- Clinical Features of Alzheimer's Disease: Cognitive and Non‐Cognitive (2010) (1)
- The trialist, meta-analyst, and journal editor: lessons from ADAPT. (2007) (1)
- Neuropsychiatric Syndromes in Dementia and MCI: Where are We Heading? (2011) (1)
- Prevention, Early Detection, and Mild Cognitive Impairment (2006) (1)
- Developing Treatments for Alzheimer's and Related Disorders with Precision Medicine: A Vision. (2021) (1)
- Nutritional status and progression of dementia: The Cache County dementia progression study (2013) (1)
- CO-DESIGNING A TRAINING PROGRAMME FOR PAID HOME CARERS TO DELIVER DEMENTIA SPECIFIC CARE TO PEOPLE AT HOME (2019) (1)
- HIV psychiatry comes of age (1996) (1)
- Design and implementation of a regional inpatient psychiatry unit for asymptomatic SARS-CoV-2 positive patients. (2020) (1)
- P1-266 Modification of cognitive trajectories: NSAID use in the Cache County study (2006) (1)
- Depression in persons with dementia in the first year after admission to a long term care facility (2000) (1)
- Interaction between C-Reactive protein level and APOE genotype in predicting rate of progression in Alzheimer's disease: The Cache County dementia progression study (2009) (1)
- Neuropsychiatric aspects of dementia (2017) (1)
- Nulliparity and late menopause are associated with less age-related cognitive decline (2000) (1)
- Diseases Causing a Cortical Pattern of Dementia (2006) (1)
- Effectiveness of a Multicomponent Care Coordination Intervention on Dementia Caregivers in the Community - a Randomized Control Trial (2013) (1)
- DEMENTIA AND HEARING CARE DISPARITIES: PREVALENCE OF PROXY-RATED HEARING LOSS AND HEARING AID USE IN A COMMUNITY-DWELLING COHORT OF DIVERSE OLDER ADULTS WITH DEMENTIA (2018) (1)
- Nutritional status and severe dementia, institutionalization, and mortality: The cache county dementia progression study (2015) (1)
- Discontinuation of Memantine Therapy in Nursing Home Residents With Alzheimer’s Disease is Associated With Increased Utilization of Psychotropic Medications and Decreased Body Weight (2008) (1)
- Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and Treatment (2022) (1)
- Rational pharmacotherapy for Alzheimer's disease (1997) (1)
- Galantamine Extended Release (2006) (1)
- Cognitive response to sertraline treatment for depression in Alzheimer's disease: A possible sex effect (2006) (1)
- Clinical Neurology for Psychiatrists, 5th ed. (2002) (1)
- P3-116 The complex role of cardiovascular risk factors, cerebrovascular disease, and gender, with the incidence of Alzheimer's disease: findings from the Cache County Study (2004) (1)
- Geriatric psychiatry: Depression in patients with Alzheimer dementia (2006) (1)
- P4-038 Classification of vascular dementia in the cardiovascular health study cognition study (2004) (1)
- How does dementia severity affect the costs of dementia care? (2013) (1)
- Review: Antidepressants improve depression in people with Alzheimer’s disease (2007) (1)
- DRUG DEVELOPMENT FOR AGITATION AND AGGRESSION IN ALZHEIMER'S DISEASE (AD): STUDY DESIGN AND OUTCOME MEASURES IN PHASE 2 STUDY OF SCYLLO-INOSITOL (ELND005 STUDY AG201) (2014) (1)
- Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force (2018) (1)
- P2-288 Neuropsychiatric symptoms in mild cognitive impairment and dementia: prevalence and relationship to cognitive and functional impairment. The Cache County Study (2004) (1)
- P4-039 Clinical and MRI factors for vascular dementia in the cardiovascular health study cognition study (2004) (1)
- P1-208 Point and five-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County study (2006) (1)
- Taming the Elephant in the Room: Interventions for Improving Dementia Care Using Technology (2016) (1)
- THE MILD BEHAVIORAL IMPAIRMENT CHECKLIST (MBI-C): A NEW RATING SCALE FOR NEUROPSYCHIATRIC SYMPTOMS AS EARLY MANIFESTATIONS OF NEURODEGENERATIVE DISEASE (2016) (1)
- Services and Developments Around the World (2013) (1)
- Neuropsychiatry and HIV infection (1994) (1)
- P1-360: Plasma ceramides are altered early in the course of Alzheimer's disease (2008) (1)
- Research Training During Psychiatric Residency (2001) (1)
- The Trap of Meaning (2017) (0)
- Support for the Family and Care Providers (2016) (0)
- Gender modifying-effect between APOE and cognitive decline in Alzheimer's disease: The Cache County dementia progression study (2011) (0)
- Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus. (2023) (0)
- Serum ceramides predict incident Alzheimer's disease: The women's health and aging study (WHAS) II (2011) (0)
- Plenary Session on Aging and Biology: Effects on Growth and Plasticity through the Lifespan (2005) (0)
- THE S-CITAD STUDY: TRIAL DESIGN AND METHODS FOR THE S-CITALOPRAM IN AGITATION TRIAL (2018) (0)
- Diseases Typically Causing Subcortical or Mixed Pattern Dementias (2006) (0)
- Diffeomorphic Mapping of Longitudinal Anatomical Shapes (2009) (0)
- Contents of The American Journal of Psychiatry (2004) (0)
- O3-08-02 DEMENTIA AND HEARING CARE DISPARITIES: PREVALENCE OF PROXY- RATED HEARING LOSS AND HEARING AID USE IN A COMMUNITY-DWELLING COHORT OF DIVERSE OLDER ADULTS WITH DEMENTIA (2018) (0)
- Association of common infections with cognitive performance in the Baltimore Epidemiologic Catchment Area study follow-up. (2023) (0)
- THE RELATIONSHIP BETWEEN CEREBRAL GLUCOSE METABOLISM AND COGNITION IN ADVANCE (2017) (0)
- Are Old-Old Patients with MDD More Likely to Relapse Than the Young-Old After Open Label Treatment with Escitalopram? (2010) (0)
- EffectofCitalopramonAgitationinAlzheimerDisease The CitAD Randomized Clinical Trial (2014) (0)
- PATTERNS AND DISPARITIES IN FORMAL DEMENTIA DIAGNOSIS AND AWARENESS OF DIAGNOSIS (2017) (0)
- P2-126 Vascular factors and the rate of cognitive decline in dementia. The Cache County Study (2006) (0)
- UNDERSTANDING THE EPIDEMIOLOGY AND RISK FACTORS FOR ALZHEIMER'S DISEASE (2005) (0)
- P-048 Regionally-specific diffusion tensor imaging measures in Alzheimer’s disease and controls (2007) (0)
- Aggression and Violence (2018) (0)
- The prion dementias. (1999) (0)
- The Johns Hopkins Comprehensive Alzheimer Program (1999) (0)
- Mental Health Issues: Crosscutting Breakout Session (2005) (0)
- Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women (2022) (0)
- P2-333 A longitudinal model for neuropsychiatric symptoms in dementia: the Cache County Study (2004) (0)
- T3. Influence of Study Population Definition on the Effect of Age at Incident Traumatic Brain Injury (2018) (0)
- Cognitive Effects of A typical A ntipsychotic M ed ications in Patients (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- Consensus provisional definition of agitation in cognitive disorders (2019) (0)
- Supportive Care for the Patient with Dementia (2006) (0)
- Dextromethorphan/quinidine (AVP-923) for treatment of agitation in patients with Alzheimer’s disease: Analysis of week 10 results for patients treated only with AVP-923 versus patients receiving only placebo (NCT01584440) (2015) (0)
- Overview of Dementia Care (2006) (0)
- Prevalence and Perception of Assistive Technology in the care of Patients with Dementia (2016) (0)
- WeCareAdvisor, an Online Platform to Help Family Caregivers Manage Dementia-Related Behavioral Symptoms: an Efficacy Trial in the Time of COVID-19 (2021) (0)
- Erratum: Sertraline for the treatment of depression in Alzheimer disease: Genetic influences (Journal of Geriatric Psychiatry and Neurology (2011) 24:4 (222-228) DOI: 10.1177/0891988711422527) (2012) (0)
- The Clinical Neuropsychiatry of Stroke (2000) (0)
- P1-157 Vascular risk factors and functional decline in dementia (2006) (0)
- Diagnostic criteria for Depression of Alzheimer disease (DAD) (2003) (0)
- Treatment of agitation in people with Alzheimer's dementia: Rationale for the clinical investigation of AVP-923 (dextromethorphan/quinidine) (2013) (0)
- Correlation of CSF beta-amyloid and tau with postoperative delirium in patients undergoing hip fracture surgery (2012) (0)
- The glymphatic system’s role in traumatic brain injury-related neurodegeneration (2023) (0)
- Psychiatric Polarities: Methodology and Practiceby Phillip R. Slavney, M.D., and Paul R. McHugh, M.D. Baltimore, Johns Hopkins University Press, 2015, 144 pp., $35.00 (paperback). (2016) (0)
- Meaningful Explanations vs Scientific Causality—Reply (2009) (0)
- External Drivers of Service Development (2013) (0)
- Plasma neopterin levels in a MCI and Alzheimer's disease (2011) (0)
- Are Migraines Protective Against Memory Decline? Results from the Baltimore Epidemiologic Catchment Area Study (2006) (0)
- SUBTYPING OF CLINICAL SUBJECTS THROUGH EXOSOME ANALYSES (2019) (0)
- Dementia and Alzheimer's disease - Part 1: Evaluation and diagnosis (2004) (0)
- New paradigms in the treatment of Alzheimer's disease. (2006) (0)
- Diagnosis and clinical management of depression in mild cognitive impairment (2004) (0)
- Now is the time for true reform of mental health services. (2015) (0)
- 41. Spect RCBF patterns and prediction of 2-year cognitive outcome in early Alzheimer's disease (1998) (0)
- Prevalence of Depressive Symptoms Among Middle-Aged and Older Adults Across Four Ethnic Groups in the Multi-Ethnic Study Of Atherosclerosis (MESA) (2006) (0)
- Ethical and Legal Issues (2006) (0)
- P2-241: Assessment of awareness of cognitive change in individuals with and without dementia: The Cache County study (2008) (0)
- Economic Analysis of the Tailored Activity Program: A Nonpharmacological Approach to Improve Quality of Life in People Living With Dementia and their Caregivers. (2023) (0)
- A population-based study of neuropsychiatric symptoms in dementia patients with and without a history of traumatic brain injury (2009) (0)
- Predictors of mortality in dementia patients upon entry into long-term care (2000) (0)
- P2-127 Longitudinal course of neuropsychiatric symptoms in dementia. The cache county study (2006) (0)
- Dementia and Alzheimer's disease - Part 2: Standards of care for patients and caregivers (2004) (0)
- Nps in normal cognition and the risk of developing MCI and dementia in the presence of late-onset nps (2015) (0)
- S-15-4 The epidemiology of psychiatric disorders in HIV infection: Depression, mania and dementia (1996) (0)
- Bridging Clinical Context With Epidemiological Concepts in Geriatric Psychiatry: Three Case Studies (2015) (0)
- The association of psychotropic medication use with cognitive, functional and neuropsychiatric outcomes in Alzheimer's disease (2012) (0)
- Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia (2015) (0)
- Erratum: Should pregnant women avoid eating fish? lessons from the Seychelles (lancet (2003) 361 (1667-1668)) (2003) (0)
- Pharmacological treatment of neuropsychiatric symptoms of dementia [3] (multiple letters) (2005) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- ADDRESSING DEMENTIA CLINICAL SYMPTOMS USING NONPHARMACOLOGICAL STRATEGIES: WHAT WORKS AND FOR WHOM? (2019) (0)
- Disease-Specific Therapies and Symptomatic Cognitive Enhancement (2016) (0)
- Does the length of time between traumatic brain injury and the onset of Alzheimer's disease affect the rate of cognitive and functional progression?: The Cache County Dementia Progression Study (2012) (0)
- IN THE WAKE OF THE ANTIPSYCHOTIC BLACK BOX WARNINGS: WHERE DO WE GO FROM HERE WITH BEHAVIORAL DISTURBANCES IN DEMENTIA? (2010) (0)
- Seven-item Restless Legs Syndrome Questionnaire (2019) (0)
- sychiatric aspects of traumatic brain injury (2002) (0)
- HEARING LOSS, HEARING AID USE, AND NEUROPSYCHIATRIC SYMPTOMS IN DEMENTIA: FINDINGS FROM NACC (2022) (0)
- Indicators of nutritional status predict neuropsychiatric symptoms in dementia: The cache county dementia progression study (2015) (0)
- Neuropsychiatric research on HIV-infected patients (1993) (0)
- P4-057: Prevalence of prodromal Alzheimer's disease across late life: Results from the Cache County Study (2008) (0)
- Treatment of agitation associated with dementia using divalproex sodium (2000) (0)
- Neurocognitive Disorder Due to Alzheimer’s Disease (2014) (0)
- Reasons for Hospitalization while Receiving Dementia Care Coordination through MIND at Home. (2022) (0)
- S-15-5 Treatment of neuropsychiatric disorders associated with HIV and AIDS (1996) (0)
- RESPONSE LETTER TO DR. FINUCANE (2008) (0)
- PREOPERATIVE CSF BIOMARKERS OF ALZHEIMER'S DISEASE IN A HIP FRACTURE POPULATION: AGE-DEPENDENT ASSOCIATION WITH UNDERLYING COGNITIVE FUNCTION (2017) (0)
- Predictors of decline in Alzheimer's: A joint analysis of cognitive, functional, and neuropsychiatric symptom change in the Cache County Dementia Progression Study (2010) (0)
- P1-051 Survival from memory symptom onset: a comparison of individuals with dementia and cognitive impairment. The cache county study (2004) (0)
- Response to Letters to the Editor the Imperative for Person-Centered Care: Focus on Assessing and Working With LTC Residents Rather Than Percent of People on Medication Without Data on Appropriate Use and Problems With DICE and BPSD. (2020) (0)
- Plasma ceramides predict hippocampal atrophy and progression in memory impairment among amnestic Mild Cognitive Impairment participants (2009) (0)
- Graphical methods for understanding changes in states: Understanding medication use pathways (2022) (0)
- The Need Ford Ementia Services of Excellence: Setting the Scene (2013) (0)
- C ognitive Effects of A typical A ntipsychotic M ed ications in P atients W ith A lzheim er's d isease: ou tcom es From C ATIE-Ad (2011) (0)
- New Clues to Preclinical Alzheimer's Disease. (2018) (0)
- Early-Onset Dementia: A Multidisciplinary Approach (2003) (0)
- STAKEHOLDER PERSPECTIVES ON HOW THE HOME CARE SECTOR CAN SUPPORT PEOPLE TO LIVE WELL WITH DEMENTIA (2019) (0)
- PATTERNS IN FORMAL DEMENTIA DIAGNOSIS AND AWARENESS OF DIAGNOSIS (2017) (0)
- Disorders of Brain and Mind (2001) (0)
- S5-02-05: Neuropsychiatric features in aging and Alzheimer's disease (2008) (0)
- DISSEMINATION OF HOME BASED DEMENTIA CARE INTERVENTIONS F2-02-01 STATUS OF THE FIELD: CLINICALTRIALS EVALUATING HOME BASED DEMENTIA CARE (2019) (0)
- Plasma markers and cognitive decline in the ADAPT clinical trial (2013) (0)
- Clinical Genetics and Dementia (2006) (0)
- Practical Dementia Care Second Edition (2005) (0)
- Supporting the Family and the Care Provider (2006) (0)
- Stability in cognitive and neurobehavioral assessments between screen and baseline in an Alzheimer’s disease trial (2015) (0)
- Neuropsychiatric Symptoms and Hearing Loss in Dementia: Unmet Need and Opportunity for Intervention (2021) (0)
- 7 Physician Attitudes and Behaviors Regarding the Assessment and Treatment of Preschool- Aged Children for Psychiatric Disorders (2011) (0)
- P3-293: Exercise to enhance hippocampal function and memory in older adults: Proof of concept findings from a 12-week exercise intervention trial (2015) (0)
- Fornix fractional anisotropy and hippocampal volume, alone and in combination, predict conversion from MCI to Alzheimer's disease (2010) (0)
- Diagnosis and Management of Delirium in the Elderly Case Study and Commentary : (0)
- P-199 Use of anti-cholinesterase inhibitors and memantine in a population-based study of incident AD cases: Prevalence of use, characteristics, and relationship to mortality (2007) (0)
- Mortality with vitamin E supplements reflects presence of severe cardiovascular disease. TheCache County Study. (2007) (0)
- there are improved treatment trials for both pharmacologi- cal and nonpharmacological interventions, clinicians may be best advised to vigilantly assess for potentially treatable symptom clusters in their patients with dementia. (2017) (0)
- P4-375 APOE-4 positive elderly taking anti-oxidant vitamins E and C in combination with NSAIDs develop less cognitive decline with aging: The Cache County study (2006) (0)
- Comparison of statistical models estimating rate of decline in a population-based cohort of persons with Alzheimer's disease: The Cache County study (2011) (0)
- Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation. (2021) (0)
- SITE-INDEPENDENT CONFIRMATION OF SUBJECT SELECTION FOR AN ALZHEIMER'S DISEASE TRIAL (2014) (0)
- CLINICIAN ’ S CORNER CARE OF THE AGING PATIENT : FROM EVIDENCE TO ACTION Nonpharmacologic Management of Behavioral Symptoms in Dementia (2012) (0)
- Noncognitive Behavioral and Neuropsychiatric Disorders (2006) (0)
- Pet imaging of translocator protein (TSPO) in elderly controls using [11C]DPA-713 (2009) (0)
- UTILITY OF AMYLOID IMAGING USING PET IN A CLINICAL SETTING (2018) (0)
- F5-04-02 UNMET NEEDS OF DEMENTIA CAREGIVERS AT HOME (2018) (0)
- Mentor: Constantine Lyketsos, M.D., M.H.S. (2005) (0)
- Research in Psychosomatic Medicine: Beginning to Set the Future Agenda (2006) (0)
- Erratum: Going beyond clinical care to reduce health care spending: Findings from the J-CHiP community-based population health management program evaluation (Medical Care (2018) 56 (603-609) DOI: 10.1097/MLR.0000000000000934) (2018) (0)
- P1‐546: WITHDRAWN (2018) (0)
- Cognitive activity and decline in Alzheimer's disease: The Cache County study (2010) (0)
- P1-258 Vascular factors are associated with increased risk of neuropsychiatric symptoms in Alzheimer’s disease (2006) (0)
- TESTING A WEB-BASED APPLICATION TO HELP INFORMAL CAREGIVERS MANAGE BEHAVIORS IN PERSONS WITH DEMENTIA: WECAREADVISORTM (2016) (0)
- of the on family caregiver outcomes in dementia: a pilot randomized controlled trial. (2018) (0)
- Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment (2012) (0)
- Dextromethorphan/quinidine (AVP-923) phase 2 study for treatment of agitation in Alzheimer’s disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440) (2015) (0)
- In this issue: article highlights (2006) (0)
- Effect of traumatic brain injury on mild behavioral impairment domains prior to all‐cause dementia diagnosis and throughout disease progression (2022) (0)
- Description and measurement of nps and their impact on dementia (2015) (0)
- WeCareAdvisor t The Development of a Caregiver-focused , Web-based Program to Assess and Manage Behavioral and Psychological Symptoms of Dementia (2016) (0)
- EMERGING FROM BETWEEN A ROCK AND A HARD PLACE: TREATING THE NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA (2011) (0)
- Practitioner’s Guide to the Neuropsychiatry of HIV/AIDS, (2000) (0)
- Three Cardinal Lessons from ADAPT - 10 Years on. (2014) (0)
- Pharmacologic and Other Biologic Treatments in Dementia (2006) (0)
- Fornix fractional anisotropy and hippocampal volume, alone and in combination, predict conversion from MCI to AD (2010) (0)
- P3-052: Neuropsychiatric syndromes in Alzheimer's disease: Relationship to cognitive and functional progression. The Cache County dementia progression study (2008) (0)
- Designing and Developing Services (2013) (0)
- THE RELATIONSHIP BETWEEN CEREBRAL GLUCOSE METABOLISM AND COGNITION IN ADVANCE (2017) (0)
- Sustained income reductions during economic recession predict depression onset in people with chronic illnesses: A 6-month prospective study (2018) (0)
- General Medical Health Rating (GMHR) 1999 (2004) (0)
- More evidence for etiologic heterogeneity of dementia in the oldest-old: a Precision Medicine approach is needed to move treatment development forward (2020) (0)
- The prevalence, role, and impact of nps in mild cognitive impairment (MCI) (2015) (0)
- Deep brain stimulation targeting the fornix for mild Alzheimer’s disease: Initial results of the advance randomized controlled trial (2015) (0)
- Family history of non-Alzheimer's Demeutia memory problems predicts rate of cognitive decline in APOE E4 non-carriers in Alzheimer's disease: The Cache County Dementia Progression Study. (2011) (0)
- Stressful Life Events and Cognitive Decline: Sex Differences in the Baltimore Epidemiologic Catchment Area Follow-Up (2016) (0)
- Atlas-based quantification with machine-learning based characterization of DTI from patients with mild cognitive impairment and Alzheimer ’ s disease (2011) (0)
- A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation (2015) (0)
This paper list is powered by the following services:
Other Resources About Constantine G. Lyketsos
What Schools Are Affiliated With Constantine G. Lyketsos?
Constantine G. Lyketsos is affiliated with the following schools:
